Literature DB >> 17899857

Danger zones: risk perceptions of young women from families with hereditary breast and ovarian cancer.

Allison V Werner-Lin1.   

Abstract

Genetic testing for hereditary breast and ovarian cancer (HBOC) is predictive, not prophetic. Families frequently rely on multigenerational stories to make sense of the inherent ambiguity as they face medical decisions and navigate life's journeys. This study asks young women with elevated genetic risk how family histories with cancer and experiences with health professionals inform their beliefs about risk and susceptibility to HBOC. Twenty-two women aged 22-36 who carry a BRCA mutation completed illness genograms and open-ended interviews. Transcripts were analyzed using a narrative tool that emphasizes the use of voice to highlight key relationships and meaning structures. Findings reveal that beliefs about risk are more firmly grounded in family experiences with cancer than in biomedical research. Pervasive meanings included (1) the presence of "danger zones," specific ages at which cancer risk was believed to increase dramatically, and (2) the experience of "the wait and the worry," in which participants felt increased urgency to achieve family development goals (i.e., child bearing) and limited control over environmental factors influencing when these goals could be met (i.e., meeting a life partner). A clinical case example and research implications are discussed.

Entities:  

Mesh:

Year:  2007        PMID: 17899857     DOI: 10.1111/j.1545-5300.2007.00215.x

Source DB:  PubMed          Journal:  Fam Process        ISSN: 0014-7370


  21 in total

1.  Beliefs and beyond: what can we learn from qualitative studies of lay people's understandings of cancer risk?

Authors:  Wendy L Lipworth; Heather M Davey; Stacy M Carter; Claire Hooker; Wendy Hu
Journal:  Health Expect       Date:  2010-06       Impact factor: 3.377

2.  Families' experience of oncogenetic counselling: accounts from a heterogeneous hereditary cancer risk population.

Authors:  Álvaro Mendes; Liliana Sousa
Journal:  Fam Cancer       Date:  2012-06       Impact factor: 2.375

3.  SI RLTD: Risk Scores and Decision Making: The Anatomy of a Decision to Reduce Breast Cancer Risk.

Authors:  Christine Holmberg; Mary Daly; Worta McCaskill-Stevens
Journal:  J Nurs Healthc Chronic Illn       Date:  2010-12

Review 4.  Family Communication, Risk Perception and Cancer Knowledge of Young Adults from BRCA1/2 Families: a Systematic Review.

Authors:  Alison L Young; Phyllis N Butow; Janine Vetsch; Veronica F Quinn; Andrea F Patenaude; Katherine M Tucker; Claire E Wakefield
Journal:  J Genet Couns       Date:  2017-06-30       Impact factor: 2.537

5.  Genetic Testing and Post-Testing Decision Making among BRCA-Positive Mutation Women: A Psychosocial Approach.

Authors:  Sharlene Hesse-Biber; Chen An
Journal:  J Genet Couns       Date:  2016-01-13       Impact factor: 2.537

6.  Segmenting by risk perceptions: predicting young adults' genetic-belief profiles with health and opinion-leader covariates.

Authors:  Rachel A Smith; Marisa Greenberg; Roxanne L Parrott
Journal:  Health Commun       Date:  2013-10-10

7.  "It was an Emotional Baby": Previvors' Family Planning Decision-Making Styles about Hereditary Breast and Ovarian Cancer Risk.

Authors:  Marleah Dean; Emily A Rauscher
Journal:  J Genet Couns       Date:  2017-01-30       Impact factor: 2.537

8.  "My funky genetics": BRCA1/2 mutation carriers' understanding of genetic inheritance and reproductive merger in the context of new reprogenetic technologies.

Authors:  Allison Werner-Lin; Lisa R Rubin; Maya Doyle; Rikki Stern; Katie Savin; Karen Hurley; Michal Sagi
Journal:  Fam Syst Health       Date:  2012-06       Impact factor: 1.950

9.  Disclosure of Positive BRCA1/2-Mutation Status in Young Couples: The Journey From Uncertainty to Bonding Through Partner Support.

Authors:  Lindsey M Hoskins; Kevin Roy; June A Peters; Jennifer T Loud; Mark H Greene
Journal:  Fam Syst Health       Date:  2008       Impact factor: 1.950

Review 10.  100 years Lynch syndrome: what have we learned about psychosocial issues?

Authors:  Eveline M A Bleiker; Mary Jane Esplen; Bettina Meiser; Helle Vendel Petersen; Andrea Farkas Patenaude
Journal:  Fam Cancer       Date:  2013-06       Impact factor: 2.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.